Rosemary Boyton
#125,426
Most Influential Person Now
British immunologist
Rosemary Boyton's AcademicInfluence.com Rankings
Rosemary Boytonbiology Degrees
Biology
#12940
World Rank
#16448
Historical Rank
Immunology
#961
World Rank
#985
Historical Rank
Download Badge
Biology
Rosemary Boyton's Degrees
- Bachelors Biology University of Oxford
Similar Degrees You Can Earn
Why Is Rosemary Boyton Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rosemary Jane Boyton is a British immunologist who is Head of Lung Immunology and Adult Infectious Disease at Imperial College London. She works on the molecular immunology of infectious, allergic and autoimmune inflammation. She holds an honorary consultant position at the Royal Brompton Hospital, where she specialises in lung infection.
Rosemary Boyton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals (2021) (342)
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose (2021) (250)
- SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection (2020) (217)
- What policy makers need to know about COVID-19 protective immunity (2020) (211)
- Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression (2009) (210)
- Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1) (2012) (196)
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 (2021) (188)
- Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses: a randomised cross-over trial (2019) (176)
- Natural killer cells, killer immunoglobulin‐like receptors and human leucocyte antigen class I in disease (2007) (169)
- Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 (2021) (162)
- Immunity to SARS-CoV-2 variants of concern (2021) (150)
- Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection (2020) (147)
- Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure (2022) (130)
- Immune boosting by B.1.1.529 (Omicron) depends on previous SARS-CoV-2 exposure (2022) (130)
- Pulmonary defences to acute respiratory infection. (2002) (112)
- Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers (2021) (99)
- Is selection for TCR affinity a factor in cytokine polarization? (2002) (77)
- High Incidence of Spontaneous Disease in an HLA-DR15 and TCR Transgenic Multiple Sclerosis Model1 (2005) (77)
- COVID-19 vaccination: The road ahead (2022) (75)
- Antibiotic therapy and outcome from immune-checkpoint inhibitors (2019) (69)
- HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. (2006) (67)
- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants (2022) (60)
- Bronchiectasis: Current Concepts in Pathogenesis, Immunology, and Microbiology. (2016) (59)
- Immune mechanisms and the impact of the disrupted lung microbiome in chronic bacterial lung infection and bronchiectasis (2013) (58)
- Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS‑CoV-2 infection (2021) (57)
- COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study (2022) (57)
- Disease‐related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis (2004) (53)
- Risk of SARS-CoV-2 reinfection after natural infection (2021) (52)
- The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions? (2021) (49)
- Glutamic acid decarboxylase T lymphocyte responses associated with susceptibility or resistance to type I diabetes: analysis in disease discordant human twins, non-obese diabetic mice and HLA-DQ transgenic mice. (1998) (48)
- Human NK cell receptor KIR2DS4 detects a conserved bacterial epitope presented by HLA-C (2019) (47)
- Infectious lung complications in patients with HIV/AIDS (2005) (46)
- T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses (2018) (45)
- Decoding the unknowns in long covid (2021) (44)
- Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma. (2009) (42)
- Canonical and Cross-reactive Binding of NK Cell Inhibitory Receptors to HLA-C Allotypes Is Dictated by Peptides Bound to HLA-C (2016) (38)
- Lung Defense through IL‐8 Carries a Cost of Chronic Lung Remodeling and Impaired Function (2018) (36)
- Human leucocyte antigen class II association in idiopathic bronchiectasis, a disease of chronic lung infection, implicates a role for adaptive immunity (2008) (35)
- Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapy. (2021) (34)
- Th1 not Th17 cells drive spontaneous MS-like disease despite a functional regulatory T cell response (2013) (32)
- T Cell Immunity to the Alkyl Hydroperoxide Reductase of Burkholderia pseudomallei: A Correlate of Disease Outcome in Acute Melioidosis (2015) (30)
- Models of multiple sclerosis (2004) (30)
- Infection with Burkholderia pseudomallei – immune correlates of survival in acute melioidosis (2017) (30)
- Transgenic models of autoimmune disease (2002) (30)
- A role of cellular prion protein in programming T‐cell cytokine responses in disease (2009) (28)
- Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F. (2015) (27)
- Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab (2022) (27)
- Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study (2021) (27)
- Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. (2005) (26)
- Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung (2006) (26)
- Waning immunity to SARS-CoV-2: implications for vaccine booster strategies (2021) (26)
- The role of natural killer T cells in lung inflammation (2008) (25)
- The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II alleles (2014) (25)
- ER-localized Hrd1 ubiquitinates and inactivates Usp15 to promote TLR4-induced inflammation during bacterial infection (2019) (24)
- Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial (2022) (22)
- CD4+ T Cell Epitopes of FliC Conserved between Strains of Burkholderia: Implications for Vaccines against Melioidosis and Cepacia Complex in Cystic Fibrosis (2014) (22)
- Increased HLA-E expression in white matter lesions in multiple sclerosis (2012) (22)
- Asthma: new developments in cytokine regulation (2004) (22)
- KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells (2015) (22)
- Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia (2020) (21)
- CD4 T Cells Selected by Antigen Under Th2 Polarizing Conditions Favor an Elongated TCRα Chain Complementarity-Determining Region 3 (2002) (20)
- IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis. (2006) (19)
- Anthrax Lethal Factor as an Immune Target in Humans and Transgenic Mice and the Impact of HLA Polymorphism on CD4+ T Cell Immunity (2014) (18)
- Regulation of immunity in bronchiectasis. (2009) (18)
- Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation (2013) (15)
- Covid-19 vaccine-induced antibodies are attenuated and decay rapidly in infliximab treated patients (2021) (15)
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 (2021) (15)
- Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2 (2021) (15)
- Rapid synchronous type 1 IFN and virus-specific T cell responses characterize first wave non-severe SARS-CoV-2 infections (2022) (14)
- Guillain-Barré syndrome and arboviral infection in Brazil. (2017) (13)
- SARS-CoV-2 variants: Subversion of antibody response and predicted impact on T cell recognition (2021) (13)
- Immune Control of Burkholderia pseudomallei––Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes (2018) (13)
- Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic (2022) (13)
- COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study (2022) (12)
- Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection (2022) (11)
- CD4+ T Cells Targeting Dominant and Cryptic Epitopes from Bacillus anthracis Lethal Factor (2016) (11)
- Pulmonary Infection with Cryptococcus neoformans in the Face of Underlying Sarcoidosis (2005) (11)
- Injectional anthrax infection due to heroin use induces strong immunological memory. (2014) (10)
- Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue Virus Immune Mothers of Congenital Zika Virus Syndrome Infants (2020) (10)
- HLA‐DR polymorphism in SARS‐CoV‐2 infection and susceptibility to symptomatic COVID‐19 (2022) (10)
- Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2 (2021) (9)
- Natural cutaneous anthrax infection, but not vaccination, induces a CD4+ T cell response involving diverse cytokines (2015) (8)
- Toll-like receptors 2 and 4 and innate immunity in neutrophilic asthma and idiopathic bronchiectasis. (2007) (8)
- Models of sarcoidosis (2006) (8)
- Healthcare workers with mild / asymptomatic SARS-CoV-2 infection show T cell responses and neutralising antibodies after the first wave (2020) (8)
- Diverse approaches to analysing the history of human and pathogen evolution: how to tell the story of the past 70 000 years (2012) (7)
- Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination (2020) (6)
- Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and Autoimmunity (2019) (6)
- Immune regulation in idiopathic bronchiectasis (2012) (6)
- MS in South Asians in England: early disease onset and novel pattern of myelin autoimmunity (2015) (5)
- Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses. (2021) (5)
- Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study (2022) (4)
- BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot Data (2016) (4)
- Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile (2014) (4)
- Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in infliximab- and vedolizumab-treated patients (2021) (4)
- The pulmonary physician in critical care • Illustrative case 5: HIV associated pneumonia (2003) (4)
- Replace 'pathogens' with 'perceptogens' (2015) (4)
- Regulatory T Cells in acute and chronic human Chikungunya infection. (2021) (4)
- Autoantigen cross-reactive environmental antigen can trigger multiple sclerosis-like disease (2015) (4)
- Serum biomarkers associated with SARS-CoV-2 severity (2022) (3)
- BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis (2021) (3)
- Phenotypical characterization of regulatory T cells in acute Zika infection. (2021) (3)
- Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody response (2022) (2)
- Multiplexed gene expression analysis of HLA class II-associated podoconiosis implicates chronic immune activation in its pathogenesis (2020) (2)
- COVID-19 Vaccine-Induced Antibody and T Cell Responses in Immunosuppressed Patients with Inflammatory Bowel Disease After the Third Vaccine Dose (2022) (2)
- Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection (2022) (2)
- HLA-C-restricted presentation of a conserved bacterial epitope to an innate NK cell receptor (2019) (2)
- OP21 COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab (2022) (1)
- OP24 Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with Inflammatory Bowel Disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study (2023) (1)
- Covid-19 caseload in the UK—assessments and mitigations (2021) (1)
- Immunology of the Microbiome: Implications for Rheumatoid Arthritis and Other Autoimmune Diseases (2018) (1)
- The impact of mesenchymal stem cells on host immunity and disease outcome in bacterial lung infection. (2020) (1)
- Muco-Obstructive Lung Diseases. (2019) (1)
- Defense Systems (2021) (1)
- KIR 2 DL 3 and KIR 2 DL 1 show similar impact on licensing of human NK cells (2015) (1)
- Is there an association between impaired pulmonary function and mortality in never smokers ? (2003) (1)
- Human leucocyte antigen (HLA) transgenic mice for the analysis of autoimmune disease (2004) (1)
- Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile (2014) (1)
- Reciprocal conditioning: T cells as regulators of dendritic cell function (2003) (1)
- A new model for analysis of chronic bronchial interleukin-8 expression (2016) (0)
- AutoimmunityImmune Responses during Infection and g Bioluminescent Reporting of In Vivo IFN-M. (2019) (0)
- Natural cutaneous anthrax infection, but not vaccination, induces a CD4+ T cell response involving diverse cytokines (2015) (0)
- ER-localized Hrd1 ubiquitinates and inactivates Usp15 to promote TLR4-induced inflammation during bacterial infection (2019) (0)
- Infection with Burkholderia pseudomallei – immune correlates of survival in acute melioidosis (2017) (0)
- OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients (2022) (0)
- Neutralising Antibody Potency Against SARS-CoV-2 Ancestral and Omicron BA.1 and BA.4/5 Variants in Patients with Inflammatory Bowel Disease after Three Doses of COVID-19 Vaccine: A Prospective Multicentre Cohort Study (CLARITY) (2022) (0)
- P535 COVID-19 vaccine-induced neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 are diminished in patients with inflammatory bowel disease on anti-TNF or JAK-inhibitor therapy (2023) (0)
- 720. Tolerisation of Mice To Allow Repeated Administration of Recombinant Sendai Virus Vector to the Airways (2004) (0)
- University of Birmingham Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses (2019) (0)
- SARS-Cov-2 immune waning and reinfection in care-home settings (2021) (0)
- Imprinted hybrid immunity against XBB reinfection (2023) (0)
- BpOmpW Antigen Stimulates the Necessary Immune Correlates of Protection Against Melioidosis (2021) (0)
- Impact of HLA Polymorphism on the Immune Response to Bacillus Anthracis Protective Antigen in Vaccination versus Natural Infection (2022) (0)
- HLA class II polymorphism influences the immune response to protective antigen and susceptibility to Bacillus anthracis (2019) (0)
- Mesenchymal stem cells enhance bacterial clearance of streptococcalpneumoniae and pseudomonasaeruginosain the lung (2016) (0)
- Identification of a quantitative trait locus for catecholamine secretion in the spontaneously hypertensive rat (1997) (0)
- Animal Models of Viral Respiratory Infections (2003) (0)
- Autoantigen cross-reactive environmental antigen can trigger multiple sclerosis-like disease (2015) (0)
- PNEUMONIA | Fungal (Including Pathogens) (2006) (0)
- Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB (2022) (0)
- This information is current as and Cepacia Complex in Cystic Fibrosis Implications for Vaccines against Melioidosis : Burkholderia between Strains of T Cell Epitopes of FliC Conserved + CD4 (2014) (0)
- Vaccine efficacy and immune interference: co-administering COVID-19 and influenza vaccines (2021) (0)
- Notch (2021) (0)
- Thank you to The Lancet Regional Health - Europe's clinical and statistical peer reviewers in 2022 (2023) (0)
- COVID-19 vaccine boosted immunity against Omicron in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors (2022) (0)
- Region 3 Chain Complementarity-Determining α TCR Polarizing Conditions Favor an Elongated CD 4 T Cells Selected by Antigen Under Th 2 (2002) (0)
- COVID-19 Vaccine-Induced Antibody Responses are Impaired in IBD Patients Treated with Infliximab or Tofacitinib, but not Thiopurines, Ustekinumab or Vedolizumab (2021) (0)
- T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses (2018) (0)
- Innate Immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1) (2012) (0)
This paper list is powered by the following services:
Other Resources About Rosemary Boyton
What Schools Are Affiliated With Rosemary Boyton?
Rosemary Boyton is affiliated with the following schools:
